Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global ARD Market Portraiture
2.2. Global ARD Market, by Drug Class, 2017 (US$ Mn)
2.3. Global ARD Market, by Geography, 2017 (US$ Mn)
Chapter 3. Anticoagulant Reversal Drugs (ARD): Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global ARD Market, by Key Players, 2017
Chapter 4. Global Anticoagulant Reversal Drugs (ARD) Market, by Drug Class, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Prothrombin Complex Concentrates (PCC)
4.3. Vitamin K
4.4. Protamine
4.5. Tranexmic Acid
4.6. Desmopressin
4.7. Idarucizumab
4.8. Andexxa
4.9. Pipeline Analysis
4.9.1. Phase III Drugs
4.9.1.1. Octaplex
4.9.2. Phase I and II Drugs (Tabular Representation)
Chapter 5. Global Anticoagulant Reversal Drugs (ARD) Market, by Geography, 2016 – 2026 (US$ Mn)
5.1. North America ARD Market Analysis, 2016 – 2026
5.1.1. North America ARD Market, by Drug Class, 2016 – 2026 (US$ Mn)
5.1.2. North America ARD Market, by Country, 2016 – 2026 (US$ Mn)
5.1.2.1. U.S.
5.1.2.2. Canada
5.2. Europe ARD Market Analysis, 2016 – 2026
5.2.1. Europe ARD Market, by Drug Class, 2016 – 2026 (US$ Mn)
5.2.2. Europe ARD Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.2.2.1. U.K.
5.2.2.2. Germany
5.2.2.3. Rest of Europe
5.3. Asia Pacific ARD Market Analysis, 2016 – 2026
5.3.1. Asia Pacific ARD Market, by Drug Class, 2016 – 2026 (US$ Mn)
5.3.2. Asia Pacific ARD Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.3.2.1. China
5.3.2.2. Japan
5.3.2.3. Rest of Asia Pacific
5.4. Latin America ARD Market Analysis, 2016 – 2026
5.4.1. Latin America ARD Market, by Drug Class, 2016 – 2026 (US$ Mn)
5.4.2. Latin America ARD Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.4.2.1. Brazil
5.4.2.2. Mexico
5.4.2.3. Rest of Latin America
5.5. Middle East & Africa ARD Market, 2016 – 2026
5.5.1. Middle East & Africa ARD Market, by Drug Class, 2016 – 2026 (US$ Mn)
5.5.2. Middle East & Africa ARD Market, by Region, 2016 – 2026 (US$ Mn)
5.5.2.1. GCC
5.5.2.2. Rest of Middle East & Africa
Chapter 6. Company Profiles
6.1. Boehringer Ingelheim GmbH
6.1.1. Business Description
6.1.2. Financial Information (Subject to Data Availability)
6.1.3. Product Portfolio
6.1.4. News Coverage
6.2. Fresenius Kabi AG
6.3. Pfizer, Inc.
6.4. Bausch Health Companies, Inc.
6.5. Amneal Pharmaceuticals, Inc.
6.6. CSL Behring Limited
6.7. Octapharma AG
6.8. Portola Pharmaceuticals, Inc.
6.9. Perosphere Pharmaceuticals, Inc.
6.10. Ferring Pharmaceuticals
List of Figures
FIG 1. Anticoagulant Reversal Drugs (ARD) Market: Research Methodology
FIG 2. ARD: Market Segmentation
FIG 3. Global ARD Market, by Drug Class, 2017 (US$ Mn)
FIG 4. Global ARD Market, by Geography, 2017 (US$ Mn)
FIG 5. Attractive Investment Proposition, by Geography, 2017
FIG 6. Competitive Analysis: Global ARD Market, by Key Players, 2017
FIG 7. Global Prothrombin Complex Concentrates (PCC) for ARD Market, 2016-2026 (US$ Mn)
FIG 8. Global Vitamin K for ARD Market, 2016-2026 (US$ Mn)
FIG 9. Global Protamine for ARD Market, 2016-2026 (US$ Mn)
FIG 10. Global Tranexmic Acid for ARD Market, 2016-2026 (US$ Mn)
FIG 11. Global Desmopressin for ARD Market, 2016-2026(US$ Mn)
FIG 12. Global Idarucizumab for ARD Market, 2016-2026(US$ Mn)
FIG 13. Global Andexxa for ARD Market, 2016-2026(US$ Mn)
FIG 14. Global Octaplex for ARD Market, (US$ Mn)
FIG 15. U.S. ARD Market, 2016-2026 (US$ Mn)
FIG 16. Canada ARD Market, 2016-2026 (US$ Mn)
FIG 17. U.K. ARD Market, 2016-2026 (US$ Mn)
FIG 18. Germany ARD Market, 2016-2026 (US$ Mn)
FIG 19. Rest of Europe ARD Market, 2016-2026 (US$ Mn)
FIG 20. China ARD Market, 2016-2026 (US$ Mn)
FIG 21. Japan ARD Market, 2016-2026 (US$ Mn)
FIG 22. Rest of Asia Pacific ARD Market, 2016-2026 (US$ Mn)
FIG 23. Brazil ARD Market, 2016-2026 (US$ Mn)
FIG 24. Mexico ARD Market, 2016-2026 (US$ Mn)
FIG 25. Rest of Latin America ARD Market, 2016-2026 (US$ Mn)
FIG 26. GCC ARD Market, 2016-2026 (US$ Mn)
FIG 27. Rest of Middle East & Africa ARD Market, 2016-2026 (US$ Mn)
List of Tables
TABLE 1 Global Anticoagulant Reversal Drugs (ARD) Market Portraiture
TABLE 2 Global ARD Market, by Drug Class, 2016 – 2026 (US$ Mn)
TABLE 3 Global Phase I and II Drug for ARD Market
TABLE 4 Global ARD Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America ARD Market, by Drug Class, 2016 – 2026 (US$ Mn)
TABLE 6 North America ARD Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 7 Europe ARD Market, by Drug Class, 2016 – 2026 (US$ Mn)
TABLE 8 Europe ARD Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 9 Asia Pacific ARD Market, by Drug Class, 2016 – 2026 (US$ Mn)
TABLE 10 Asia Pacific ARD Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Latin America ARD Market, by Drug Class, 2016 – 2026 (US$ Mn)
TABLE 12 Latin America ARD Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 13 Middle East & Africa ARD Market, by Drug Class, 2016 – 2026 (US$ Mn)
TABLE 14 Middle East & Africa ARD Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 15 Boehringer Ingelheim GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 16 Fresenius Kabi AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 17 Pfizer, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 18 Bausch Health Companies, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 19 Amneal Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 20 CSL Behring Limited: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Octapharma AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Portola Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Perosphere Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Ferring Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)